Health Technology, Digital Healthcare

KARL STORZ Receives Innovative Technology Designation from Vizient for TIPCAM1 Rubina with ARTip SOLO Robotic Assistance

KARL STORZ

KARL STORZ Endoscopy-America, Inc., proudly announces its TIPCAM®1 Rubina® with ARTip® SOLO robotic assistance has received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the country. KARL STORZ exhibited TIPCAM1 Rubina with ARTip SOLO at the Vizient Innovative Technology Exchange on Oct. 17 in Dallas, Texas.

Each year, healthcare experts serving on Vizient member-led councils review select products and technologies for their potential to enhance clinical care, patient safety, and healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers that these innovations can have a positive impact on patient care and business models.

TIPCAM1 Rubina is the only advanced endoscopic solution on the market that gives surgeons access to the most sophisticated visualization technologies of 4K imaging in 2D, 3D, and NIR/ICG, all in one video endoscope using ONE system, the KARL STORZ IMAGE1™ S. The ARTip SOLO robotic camera guidance system, paired with the TIPCAM1 Rubina, allows the operating surgeon to maintain stability and precise control of the field of view. This improves the environment to train surgeons on technical skills, enabling them to operate alone—which can improve efficiency, thereby lowering overall costs. It also provides ideal ergonomics, especially in long procedures.

Advanced technologies such as 4K 3D and 4K NIR/ICG provide the ability to visualize crucial details during surgery, often resulting in improved safety and outcomes. 3D has shown to improve task completion time by 64% and reduce errors by 63% especially where suturing is involved. NIR/ICG can reduce complication rates through assessment of blood flow and visualization of critical anatomy.

Due to the complexities in surgery, having access to different tools can give a surgeon confidence to properly assess and create a safe surgical plan. The unique combination of the TIPCAM1 Rubina and ARTip SOLO allows hospitals to bridge the gap between robotics and laparoscopy by recreating a robotic experience, incorporating advanced technologies that deliver value without the large capital expense.

KARL STORZ is committed to delivering quality products to allow for optimal surgical flow and advanced patient care. Desirable patient outcomes and improved surgeon ergonomics and autonomy, along with ease of setup enhancing operating room workflow, are just a few of the benefits offered by this innovative endoscopic solution. The advancement in imaging with streamlined robotic assistance allows for use across multiple surgical specialties, in both hospital and ambulatory care settings in rural and urban patient populations, providing equitable access to health care.”

Aarathi Cholkeri-Singh, MD, Medical Director at KARL STORZ Endoscopy-America, Inc

“Healthcare experts on Vizient member councils evaluated TIPCAM1 Rubina with ARTip SOLO robotic assistance as part of the Innovative Technology Program,” said Kelly Flaharty, Vizient Senior Director of Contract Services. “This designation indicates TIPCAM1 Rubina with ARTip SOLO robotic assistance has one or more qualities that differentiate it from similar products and has potential to make an incremental improvement in healthcare. Congratulations to KARL STORZ.”

KARL STORZ Endoscopy-America, Inc., proudly announces its TIPCAM®1 Rubina® with ARTip® SOLO robotic assistance has received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the country. KARL STORZ exhibited TIPCAM1 Rubina with ARTip SOLO at the Vizient Innovative Technology Exchange on Oct. 17 in Dallas, Texas.

Each year, healthcare experts serving on Vizient member-led councils review select products and technologies for their potential to enhance clinical care, patient safety, and healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers that these innovations can have a positive impact on patient care and business models.

TIPCAM1 Rubina is the only advanced endoscopic solution on the market that gives surgeons access to the most sophisticated visualization technologies of 4K imaging in 2D, 3D, and NIR/ICG, all in one video endoscope using ONE system, the KARL STORZ IMAGE1™ S. The ARTip SOLO robotic camera guidance system, paired with the TIPCAM1 Rubina, allows the operating surgeon to maintain stability and precise control of the field of view. This improves the environment to train surgeons on technical skills, enabling them to operate alone—which can improve efficiency, thereby lowering overall costs. It also provides ideal ergonomics, especially in long procedures.

Advanced technologies such as 4K 3D and 4K NIR/ICG provide the ability to visualize crucial details during surgery, often resulting in improved safety and outcomes. 3D has shown to improve task completion time by 64% (44 of 69 studies) and reduce errors by 63% (28 of 45 studies), especially where suturing is involved. NIR/ICG can reduce complication rates through assessment of blood flow and visualization of critical anatomy.

Due to the complexities in surgery, having access to different tools can give a surgeon confidence to properly assess and create a safe surgical plan. The unique combination of the TIPCAM1 Rubina and ARTip SOLO allows hospitals to bridge the gap between robotics and laparoscopy by recreating a robotic experience, incorporating advanced technologies that deliver value without the large capital expense.

“KARL STORZ is committed to delivering quality products to allow for optimal surgical flow and advanced patient care. Desirable patient outcomes and improved surgeon ergonomics and autonomy, along with ease of setup enhancing operating room workflow, are just a few of the benefits offered by this innovative endoscopic solution,” said Aarathi Cholkeri-Singh, MD, Medical Director at KARL STORZ Endoscopy-America, Inc. “The advancement in imaging with streamlined robotic assistance allows for use across multiple surgical specialties, in both hospital and ambulatory care settings in rural and urban patient populations, providing equitable access to health care.”

“Healthcare experts on Vizient member councils evaluated TIPCAM1 Rubina with ARTip SOLO robotic assistance as part of the Innovative Technology Program,” said Kelly Flaharty, Vizient Senior Director of Contract Services. “This designation indicates TIPCAM1 Rubina with ARTip SOLO robotic assistance has one or more qualities that differentiate it from similar products and has potential to make an incremental improvement in healthcare. Congratulations to KARL STORZ.”

About Vizient
Vizient represents a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks, and non-acute healthcare providers and represents approximately $130 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

About KARL STORZ
KARL STORZ Endoscopy-America, Inc. is an innovative leader in endoscopic technology and imaging solutions across virtually all surgical specialties. KARL STORZ provides solutions that facilitate operational and workflow efficiencies across various sites of care, so healthcare providers can deliver optimal patient care in the most cost-effective manner. The group is an affiliate of KARL STORZ SE & Co. KG, an international leader and family-owned company based in Tuttlingen, Germany, that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness. 


 

Spotlight

Spotlight

Related News

Health Technology

Rudolf Riester GmbH Announces Global Market Launch of Telemedicine Solution, Showcases ri-sonic® E-Stethoscope + eMurmur® AI Integration

Rudolf Riester GmbH | January 29, 2024

Rudolf Riester GmbH, a global leader in medical technology, proudly announces the full market launch of its comprehensive Telemedicine offering. Already in active use across Europe, the Middle East, and Africa, the solution from the trusted Riester brand delivers industry-leading quality and versatility through integration of a broad range of medical devices to meet the needs of diverse user scenarios. "Since its founding 75 years ago, Riester has been a pioneer in providing accurate and efficient diagnostic devices for front-line healthcare. We have brought this passion and expertise to the creation of our telemedicine solution," said Dr. Georgiana Gasquères, Global Business Unit Director, Telemedicine at Riester. "Now we empower healthcare providers worldwide with the tools they need to deliver accurate diagnosis and exceptional care to every patient, everywhere, and to do it more sustainably." Riester is demonstrating its Telemedicine Case and Cart offerings at the Arab Health show in Dubai, 29 January – 1 February 2024, at booth SA.E30. Traveling nurses with South African healthcare innovator EQiGate are already evaluating dozens of patients every week with the Riester Telemedicine Case. "EQiGate selected the Riester Telemedicine solution for its high quality, comprehensiveness, and versatile, Windows-based compatibility with our portfolio of operating applications," stated Braam Kruger, CEO at EQiGate. "The Riester solution integrates seamlessly with our Hospital at Home concept, enabling us to bring the hospital to the patient, a healthcare paradigm shift that yields significant cost and time savings for both the healthcare system and the patient." At Arab Health, Riester is showcasing the integration of their industry-leading ri-sonic® E-stethoscope with the eMurmur® AI platform. Digital auscultation with ri-sonic and eMurmur AI enables the early detection and analysis of heart murmurs, informing better, more timely decisions about treatment pathways. To demonstrate their commitment to raising heart health awareness and improving quality of life through accurate and efficient diagnosis, Riester is offering complimentary advisory heart checks to all exhibition attendees at their booth at Arab Health, conducted by a professional cardiologist. "Our participation at Arab Health reaches beyond showcasing our technological advancements; it is about educating and engaging with the public – including Arab Health attendees – and healthcare professionals," said Irina Zhdanova, CEO of Riester. "By providing free advisory heart checks, we emphasise the significance of regular cardiac health assessments and demonstrate how innovative technology can be a pivotal tool in advancing diagnostic cardiac care to improve health outcomes. This is a perfect way to honor Riester’s 75-year heritage and act on our vision and mission." About Rudolf Riester GmbH Since its founding in Germany in 1948, Rudolf Riester GmbH has been a pioneering force in improving quality of life through accurate and efficient diagnosis on the front-line of healthcare. By developing and manufacturing high-quality, market-leading medical diagnostic products, Riester has earned a global reputation for quality, reliability, and innovation in the healthcare sector, with a presence in over 150 countries. Specializing in diagnostic devices, Riester's product portfolio includes telemedicine solutions as well as stethoscopes, blood pressure monitors, otoscopes, ophthalmoscopes, and other medical equipment. Riester is part of the Halma plc group of companies.

Read More

Healthcare Analytics

Keystone Healthcare Partners Establishes Partnership with Trinity Medical to Expand Emergency Medicine Footprint into Louisiana

Keystone Healthcare Partners | February 05, 2024

Keystone Healthcare Partners a leading provider of emergency medicine, hospital medicine, critical care medicine, and telehealth staffing and management services, as well as revenue cycle management, recently announced that it has formed a partnership with Trinity Medical in Ferriday, Louisiana. Keystone's delivery of emergency medicine services at Trinity Medical will commence on February 1, 2024. This contract represents an exciting expansion of Keystone's regional influence into Louisiana; the company has managed contracts in Mississippi for decades. Glenn Adams, Keystone's CEO & Co-founder, notes, "We are excited to kick off another partnership with a client where we see opportunity for real impact. We've hit the ground running to shore up areas of frustration for the client and bring value-add and innovative solutions, such as Keystone Connect AI technology to the emergency medicine program." While the healthcare landscape has been challenging for rural and critical access hospitals, the two entities share a patient-centered ethos that will be paramount to the partnership. The two entities share a community- and patient-focus that is embodied by Trinity's motto, "People you know, caring for people you love." "We are very excited to start our partnership with Keystone Healthcare," states Keisha Smith, CEO of Trinity. "My goal for Trinity Medical has always been to provide our patients with the best healthcare and customer service possible in the Miss-Lou area. We feel that Keystone shares the same goals that we have and will be a true asset to our hospital. Henry Ford stated, 'Coming together is a beginning, staying together is progress, and working together is success.' We are looking forward to a long lasting, successful partnership with Keystone Healthcare." Trinity Medical, a 23-bed licensed facility, continues to grow and upgrade their services and facilities in addition to recruiting physicians to meet the growing needs of their expanding community. About Keystone Healthcare Keystone Healthcare™ is a leading provider of Emergency Medicine, Hospital Medicine, Critical Care Medicine and Telehealth clinical management services and staffing solutions for hospitals. We efficiently deliver high-quality, patient-centered care through strong physician leadership and involved management that drive our innovative and integrated business model. About Trinity Medical Trinity Medical is operated by Concordia Parish Hospital Service District No. 1. Trinity Medical, formerly Riverland Medical Center, opened in 1964 as Concordia Parish Hospital and has continuously served the residents of the area for more than 55 years. In addition to emergency and acute care, Trinity Medical offers surgical services, diagnostic imaging, infusion center, cardio-respiratory care, gastroenterology, lab services, otolaryngology, urology, and an in-hospital rehabilitation service as well as an extensive range of out-patient services, both diagnostic and for treatment.

Read More

Health Technology

Beckman Coulter Unveils DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance

Beckman Coulter Diagnostics | January 30, 2024

Beckman Coulter Diagnostics, a clinical diagnostics leader, will unveil its new DxC 500 AU Chemistry Analyzer, an automated clinical chemistry analyzer, at Medlab Middle East in Dubai, taking place February 5-8, 2024. The DxC 500 AU Chemistry Analyzer is one of several recent Beckman Coulter solutions designed to address the complete needs of healthcare systems that are looking to complement central hub laboratories by advancing the technology and capabilities of satellite and independent hospital laboratories. "Healthcare systems around the world are strategically adopting hub-and-spoke models for better efficiency and healthcare access," said Kathleen Orland, Senior Vice President, Business Unit, General Manager, Chemistry and Immunoassay for Beckman Coulter Diagnostics. "Hub-and-spoke clinical laboratory models optimize resources to improve access to testing services and enhance overall standardization for quality testing and positive impact on inventory and cost management across a health system. The new DxC 500 AU Chemistry Analyzer advances capabilities of spoked labs with a broad menu of high-quality assays that deliver consistent, commutable results across Beckman Coulter's AU clinical chemistry systems, positively impacting clinical decision-making and patient outcomes." The DxC 500 AU Chemistry Analyzer features advanced automation technology, onboard guided workflows, and standardized reagents for use across healthcare networks. Its menu of more than 120 assays has been independently and objectively verified for high quality Six Sigma performance, supporting confidence in clinical results, reducing QC trouble shooting and lab operational costs. "Our Six Sigma assessment has shown that the DxC 500 AU analyzer easily exceeds the demands of the new, more stringent CLIA 2024 performance specifications," stated Sten Westgard, Director of Client Services and Technology for Westgard QC. The DxC 500 AU Chemistry Analyzer is for in vitro diagnostic use only. It is available throughout North America and the Middle East. Global commercial availability is planned for March 2024. About Beckman Coulter. Inc. A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory's role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what's now to what's next. We seek to accelerate care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, Calif., with more than 11,000 global team members, Beckman Coulter Diagnostics is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow's science and technology to improve human health. ©2024 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Read More